Conference
Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial
Authors
De Vries TI; Eikelboom JW; Bosch J; Westerink J; Dorresteijn JAN; Alings M; Dyal L; Berkowitz SD; Van der Graaf Y; Fox KAA
Volume
40
Pagination
pp. 1274-1274
Publisher
OXFORD UNIV PRESS
Publication Date
October 1, 2019
Name of conference
Congress of the European-Society-of-Cardiology (ESC) / World Congress of Cardiology
Conference place
Paris, FRANCE
Conference start date
August 31, 2019
Conference end date
September 4, 2019
Conference proceedings
EUROPEAN HEART JOURNAL
ISSN
0195-668X